NAUREX INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for NAUREX INC..The latest application filed is for "solid forms of tert-butyl (s)-2((2s,3r)-1-amino-3-hydroxy-1-oxobu tan-2-yl)-1-oxo-2, 5-diazaspiro [3.4] octan e-5-carboxylate and methods of preparing them".

Company Profile

11.7.27

NAUREX INC. - Madison NJ US
NAUREX, INC - Madison NJ US
Naurex, Inc. - Parsippany NJ US
Naurex, Inc. - Parisppany NJ US
Naurex, Inc. - Evanston IL US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Solid Forms Of Tert-butyl (s)-2((2s,3r)-1-amino-3-hydroxy-1-oxobu Tan-2-yl)-1-oxo-2, 5-diazaspiro [3.4] Octan E-5-carboxylate And Methods Of Preparing Them App 20220267341 - YUAN; Xiaoda ; et al.	2022-08-25
Processes And Intermediates For Producing Diazaspiro Lactam Compounds App 20220259217 - DINH; Danny T. ; et al.	2022-08-18
Process And Intermediates For Synthesis Of Peptide Compounds App 20220112239 - RACHA; Saibaba	2022-04-14
Salt And Crystalline Forms Of Rapastinel App 20220024976 - WU; Ke	2022-01-27
Process For Synthesis Of Peptide Compounds App 20210198315 - KHAN; M. Amin	2021-07-01
Treatment With Nmda Receptor Modulators App 20200368310 - Banerjee; Pradeep ; et al.	2020-11-26
Stable Compositions Of Neuroactive Peptides App 20200254050 - Kind Code	2020-08-13
Process And Intermediates For Synthesis Of Peptide Compounds App 20200199173 - Racha; Saibaba	2020-06-25
Treatment With Nmda Receptor Modulators App 20200197365 - Banerjee; Pradeep ; et al.	2020-06-25
NMDA receptor modulators and prodrugs, salts, and uses thereof Grant 10,590,167 - Khan	2020-03-17
Methods Of Administration Of Nmda Receptor Agonists App 20190351006 - Banerjee; Pradeep ; et al.	2019-11-21
Process And Intermediates For Synthesis Of Peptide Compounds App 20190031715 - Racha; Saibaba	2019-01-31
N-methyl-d-aspartate Receptor Modulators And Methods Of Making And Using Same App 20180258139 - Khan; M. Amin	2018-09-13
N-methyl-D-aspartate receptor modulators and methods of making and using same Grant 9,994,614 - Khan June 12, 2	2018-06-12
Nmda Receptor Modulators And Prodrugs, Salts, And Uses Thereof App 20180127466 - Khan; Amin	2018-05-10
Methods Of Treating Depression Using Nmda Modulators App 20170296616 - Burch; Ron	2017-10-19
NMDA receptor modulators and prodrugs, salts, and uses thereof Grant 9,745,342 - Khan August 29, 2	2017-08-29
N-methyl-d-aspartate Receptor Modulators And Methods Of Making And Using Same App 20170210779 - Khan; Amin M.	2017-07-27
Spiro-lactam NMDA receptor modulators and uses thereof Grant 9,708,335 - Lowe, III , et al. July 18, 2	2017-07-18
Stable Compositions Of Neuroactive Peptides App 20170049844 - HOUCK; DAVID ; et al.	2017-02-23
Nmda Receptor Modulators And Prodrugs, Salts, And Uses Thereof App 20160244485 - Khan; Amin	2016-08-25
Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20160122359 - Lowe, III; John A. ; et al.	2016-05-05
Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20150376195 - Lowe, III; John A. ; et al.	2015-12-31
Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20150368254 - Lowe, III; John A. ; et al.	2015-12-24
Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20150368253 - Lowe, III; John A. ; et al.	2015-12-24
Spiro-lactam Nmda Receptor Modulators And Uses Thereof App 20150368252 - Lowe, III; John A. ; et al.	2015-12-24
Hydroxamic Acid Derivatives, Preparation and Therapeutic Uses Thereof App 20140045943 - Khan; Amin ; et al.	2014-02-13

Company Registrations

NCAGE Code	5C5A2	NAUREX INC.
NCAGE Code	47FQ0	NAUREX INC.!DBA NAUREX
CAGE Code	47FQ0	NAUREX INC. NAUREX
CAGE Code	5C5A2	NAUREX INC.
DUNS	829644736	NAUREX INC.
SEC	0001467762	Naurex Inc. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.